Breakthrough in treatment of hepatitis C
Links shared publicly online about this topic.
- 199total visits
Breakthrough in treatment of hepatitis C
View full resource at sciencedaily.com
Tags: Liver Condition, Hepatitis, Hepatitis C, Infection, Drug, Telaprevir
Most Recently Shared on June 23, 2011 at 3:29 am By:
Breakthrough in treatment of hepatitis C: The drug telaprevir (Incivek) provides a dramatic improvement in... http://tinyurl.com/5secxbr
POZ - Treatment News : FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted HIV Protease Inhibitors - by Tim Horn
poz.com — “Victrelis (boceprevir), Merck?s hepatitis C virus (HCV) protease inhibitor, should not be combined with the following Norvir (ritonavir)-boosted HIV protease inhibitors: Reyataz (atazanavir), Prezista (darunavir) or Kaletra.” View full resource at poz.com
Most Recently Shared on April 28, 2012 at 2:40 am By:
Health Literacy Medical School
Contentment Linked to Balanced View of One's Past, Present & Future - Not over valuing 1 > another http://t.co/LGB4FOTP @sciencedaily
82% Hepatitis C Cure Rate Achieved In Large Trial
medicalnewstoday.com — “Up to 82% of patients with hepatitis C achieved viral cure after 28 weeks' treatment with a combination of Boehringer Ingelheim's investigational antiviral agents - the protease inhibi” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2012 at 4:05 pm By:
82% Hepatitis C Cure Rate Achieved In Large Trial http://t.co/9XEo2TyV #healthnews
Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure
medicalnewstoday.com — “According to new data from the largest Phase II interferon-free trial to date, after only 28 weeks of treatment, almost 82% of hepatitis C patients achieved a viral cure. The results were achieve” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2012 at 8:05 pm By:
Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure http://t.co/PMIB5efb #healthnews
HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the… http://t.co/es8fhWgM
Abbott hepatitis drug 93% effective in small study - chicagotribune.com
chicagotribune.com — “A combination of experimental oral hepatitis C treatments being developed by Abbott Laboratories led to cure rates of more than 90 percent in previously untreated patients, according to data from a small mid-stage study.” View full resource at chicagotribune.com
Most Recently Shared on April 4, 2012 at 2:57 pm By:
John Carroll Health Communicator
Abbott is wowing the crowd with hep C data. from Reuters: http://t.co/6NZkH69v
ACP Internist: Is treatment for hepatitis C hype or hope? Big win for big pharm
blog.acpinternist.org — “ACP Internist: Is treatment for hepatitis C hype or hope? Big win for big pharm” View full resource at blog.acpinternist.org
Most Recently Shared on April 4, 2012 at 1:36 pm By:
From the blog: Is treatment for hepatitis C hype or hope? Big win for big pharm http://t.co/cTpOl47Z
Tremelimumab Shows Promise in Treatment of Liver Cancer
aacr.org — “Tumor burden reduction and disease stabilization occurred in some cases. Tremelimumab also reduced blood levels of hepatitis C virus. CHICAGO — Tremelimumab treatment stabilized patients with advanced hepatocellular carcinoma due to chronic hepatitis C infection for more than 12 months, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.Researchers evaluated 21 patients treated with tremelimumab intravenously at a dose of 15 mg/kg every 90 days for ab” View full resource at aacr.org
Most Recently Shared on April 3, 2012 at 12:29 am By:
Dr. P. D Tapp Doctor, Health Executive, and PhD
Tremelimumab Shows Promise in Treatment of Liver Cancer: http://t.co/tATE1IqK
Boceprevir and telaprevir for the treatment of chronic hepatitis C gen
dovepress.com — “Peer reviewed article authored by (Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ). Read article or submit your manuscript for publishing.” View full resource at dovepress.com
Most Recently Shared on March 27, 2012 at 4:32 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Boceprevir and telaprevir hepatitis C genotype 1:an indirect comparison meta-analysishttp://www.dovepress.com/articles.php?article_id=9446
HCV New Drug Research: Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 19, 2012 at 4:59 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or… http://t.co/f8yyQzUK
HCV New Drug Research: Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 19, 2012 at 4:38 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Treatment of chronic #hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir http://t.co/7n0FLVar
Study Suggests Broader Screening For Hepatitis C - QualityPoint Technologies
qualitypointtech.net — “Broader screening to identify people infected with hepatitis C virus (HCV) would likely be cost effective, according to a new report published in Clinical Infectious Diseases and available online. Significantly reducing HCV-related mortality and morbidity, however, will require a coordinated effort that emphasizes not only increased testing but also linking those infected with the treatment they need. The HCV epidemic peaked many years ago, but roughly 4 million U.S. residents still suffer the c” View full resource at qualitypointtech.net
Most Recently Shared on March 17, 2012 at 9:00 am By:
Study Suggests Broader Screening For Hepatitis C: Broader screening to identify people infected with hepatitis C v... http://t.co/fgkhOcQ4
Okairos launches pioneering mid-stage study of promising hep C vaccine - FierceBiotech
fiercebiotech.com — “As far as most biotech investors are concerned, the most exciting work being done in the hepatitis C field involves next-gen treatments that can potentially quell the virus without the need for the Read more...” View full resource at fiercebiotech.com
Most Recently Shared on March 14, 2012 at 4:17 pm By:
John Carroll Health Communicator
Okairos launches pioneering mid-stage study of promising hep C vaccine - http://t.co/yaOg6w8l
Hundreds Of New Yorkers Attend Annual Hepatitis C Legislative Awareness Day To Request State Plan For 2013 - Press Release - Digital Journal
digitaljournal.com — “Albany, NY (PRWEB) March 14, 2012 Status C Unknown, a non-profit 501(c)3 today led hundreds of patients and advocates from around New York State to Albany for the sixth annual Hepatitis C Legislative Awareness Day, urging lawmakers to adopt a plan for 2013 to combat the increasing incidence of hepatitis C infection in New York State with education, testing and treatment programs. The request comes just weeks after the U.S. Centers for Disease Control & Prevention (CDC) reported that more America” View full resource at digitaljournal.com
Most Recently Shared on March 14, 2012 at 3:45 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hundreds Of New Yorkers Attend Annual #Hepatitis C Legislative Awareness Day http://t.co/NPQtUmBq
Infectious Disease Medical Article | Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations
mdlinx.com — “Infectious Disease Medical Article: Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations” View full resource at mdlinx.com
Most Recently Shared on March 13, 2012 at 2:36 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recomm... http://t.co/QOlHLLff #ID
C.S. Mott Children's Hospital - Hospital - Ann Arbor, MI - Events | Facebook
facebook.com — “C.S. Mott Children's Hospital - Where the Leaders and Best come together with advanced technologies and breakthrough treatments that change children's lives. . Comments on this page are monitored for courtesy and relevance. | Facebook” View full resource at facebook.com
Most Recently Shared on March 13, 2012 at 2:34 pm By:
.@A2WithKids Thanks for sharing info about upcoming #MottChildren web chats! Full schedule: http://t.co/QmsVdHw8
Advertisement
